• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

AMPK 与治疗低氧性肺动脉高压的挑战。

AMPK and the Challenge of Treating Hypoxic Pulmonary Hypertension.

机构信息

Institute of Health Studies, University Arturo Prat, Av. Arturo Prat 2120, Iquique 1110939, Chile.

Institute DECIPHER, German-Chilean Institute for Research on Pulmonary Hypoxia and Its Health Sequelae, 20251 Hamburg, Germany and Iquique 1100000, Chile.

出版信息

Int J Mol Sci. 2022 Jun 1;23(11):6205. doi: 10.3390/ijms23116205.

DOI:10.3390/ijms23116205
PMID:35682884
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9181235/
Abstract

Hypoxic pulmonary hypertension (HPH) is characterized by sustained elevation of pulmonary artery pressure produced by vasoconstriction and hyperproliferative remodeling of the pulmonary artery and subsequent right ventricular hypertrophy (RVH). The search for therapeutic targets for cardiovascular pathophysiology has extended in many directions. However, studies focused on mitigating high-altitude pulmonary hypertension (HAPH) have been rare. Because AMP-activated protein kinase (AMPK) is involved in cardiovascular and metabolic pathology, AMPK is often studied as a potential therapeutic target. AMPK is best characterized as a sensor of cellular energy that can also restore cellular metabolic homeostasis. However, AMPK has been implicated in other pathways with vasculoprotective effects. Notably, cellular metabolic stress increases the intracellular ADP/ATP or AMP/ATP ratio, and AMPK activation restores ATP levels by activating energy-producing catabolic pathways and inhibiting energy-consuming anabolic pathways, such as cell growth and proliferation pathways, promoting cardiovascular protection. Thus, AMPK activation plays an important role in antiproliferative, antihypertrophic and antioxidant pathways in the pulmonary artery in HPH. However, AMPK plays contradictory roles in promoting HPH development. This review describes the main findings related to AMPK participation in HPH and its potential as a therapeutic target. It also extrapolates known AMPK functions to discuss the less-studied HAPH context.

摘要

低氧性肺动脉高压(HPH)的特征是肺动脉收缩和增生性重塑导致肺动脉压持续升高,随后出现右心室肥厚(RVH)。针对心血管病理生理学的治疗靶点的研究已经扩展到许多方向。然而,针对高原性肺动脉高压(HAPH)的研究却很少。由于 AMP 激活的蛋白激酶(AMPK)参与心血管和代谢病理学,因此 AMPK 通常被视为潜在的治疗靶点。AMPK 最显著的特征是作为细胞能量的传感器,也可以恢复细胞代谢的动态平衡。然而,AMPK 还参与了具有血管保护作用的其他途径。值得注意的是,细胞代谢应激会增加细胞内 ADP/ATP 或 AMP/ATP 的比值,AMPK 的激活通过激活产生能量的分解代谢途径和抑制消耗能量的合成代谢途径(如细胞生长和增殖途径)来恢复 ATP 水平,从而促进心血管保护。因此,AMPK 的激活在 HPH 肺动脉中的抗增殖、抗肥大和抗氧化途径中发挥重要作用。然而,AMPK 在促进 HPH 发展中发挥着矛盾的作用。这篇综述描述了与 AMPK 参与 HPH 及其作为治疗靶点的潜力相关的主要发现,并从已知的 AMPK 功能推断出较少研究的 HAPH 背景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6075/9181235/84bf7e98b610/ijms-23-06205-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6075/9181235/3061c850d9bc/ijms-23-06205-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6075/9181235/3fc7def7e37e/ijms-23-06205-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6075/9181235/c1cf6de43f66/ijms-23-06205-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6075/9181235/84bf7e98b610/ijms-23-06205-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6075/9181235/3061c850d9bc/ijms-23-06205-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6075/9181235/3fc7def7e37e/ijms-23-06205-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6075/9181235/c1cf6de43f66/ijms-23-06205-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6075/9181235/84bf7e98b610/ijms-23-06205-g004.jpg

相似文献

1
AMPK and the Challenge of Treating Hypoxic Pulmonary Hypertension.AMPK 与治疗低氧性肺动脉高压的挑战。
Int J Mol Sci. 2022 Jun 1;23(11):6205. doi: 10.3390/ijms23116205.
2
Regulatory effect of AMP-activated protein kinase on pulmonary hypertension induced by chronic hypoxia in rats: in vivo and in vitro studies.AMP激活的蛋白激酶对大鼠慢性低氧诱导的肺动脉高压的调控作用:体内和体外研究
Mol Biol Rep. 2014 Jun;41(6):4031-41. doi: 10.1007/s11033-014-3272-9. Epub 2014 Feb 25.
3
The Protective Effects of Κ-Opioid Receptor Stimulation in Hypoxic Pulmonary Hypertension Involve Inhibition of Autophagy Through the AMPK-MTOR Pathway.κ-阿片受体刺激对缺氧性肺动脉高压的保护作用涉及通过AMPK-MTOR途径抑制自噬。
Cell Physiol Biochem. 2017;44(5):1965-1979. doi: 10.1159/000485886. Epub 2017 Dec 8.
4
Notch4 mediates vascular remodeling via ERK/JNK/P38 MAPK signaling pathways in hypoxic pulmonary hypertension.Notch4 通过 ERK/JNK/P38MAPK 信号通路介导低氧性肺动脉高压中的血管重塑。
Respir Res. 2022 Jan 11;23(1):6. doi: 10.1186/s12931-022-01927-9.
5
Adenosine monophosphate-activated protein kinase is required for pulmonary artery smooth muscle cell survival and the development of hypoxic pulmonary hypertension.一磷酸腺苷激活蛋白激酶对于肺动脉平滑肌细胞的存活和低氧性肺动脉高压的发展是必需的。
Am J Respir Cell Mol Biol. 2013 Oct;49(4):609-18. doi: 10.1165/rcmb.2012-0446OC.
6
New insights into activation and function of the AMPK.对AMPK激活及功能的新见解。
Nat Rev Mol Cell Biol. 2023 Apr;24(4):255-272. doi: 10.1038/s41580-022-00547-x. Epub 2022 Oct 31.
7
Hydroxysafflor yellow A (HSYA) attenuates hypoxic pulmonary arterial remodelling and reverses right ventricular hypertrophy in rats.羟基红花黄色素A(HSYA)可减轻大鼠缺氧性肺动脉重塑并逆转右心室肥厚。
J Ethnopharmacol. 2016 Jun 20;186:224-233. doi: 10.1016/j.jep.2016.04.004. Epub 2016 Apr 5.
8
Hypoxia-induced changes in plasma micro-RNAs correlate with pulmonary artery pressure at high altitude.高原缺氧诱导的血浆 micro-RNAs 变化与肺动脉压相关。
Am J Physiol Lung Cell Mol Physiol. 2018 Jan 1;314(1):L157-L164. doi: 10.1152/ajplung.00146.2017. Epub 2017 Sep 28.
9
CPT1 regulates the proliferation of pulmonary artery smooth muscle cells through the AMPK-p53-p21 pathway in pulmonary arterial hypertension.CPT1 通过 AMPK-p53-p21 通路调控肺动脉平滑肌细胞增殖在肺动脉高压中起作用。
Mol Cell Biochem. 2019 May;455(1-2):169-183. doi: 10.1007/s11010-018-3480-z. Epub 2018 Dec 3.
10
C1q/TNF-related protein-9 ameliorates hypoxia-induced pulmonary hypertension by regulating secretion of endothelin-1 and nitric oxide mediated by AMPK in rats.C1q/TNF 相关蛋白-9 通过调节 AMPK 介导的内皮素-1 和一氧化氮的分泌来改善大鼠低氧性肺动脉高压。
Sci Rep. 2021 May 31;11(1):11372. doi: 10.1038/s41598-021-90779-2.

引用本文的文献

1
Isoform-specific roles of AMP-activated protein kinase in cardiac physiology and pathophysiology.AMP激活的蛋白激酶在心脏生理和病理生理中的亚型特异性作用。
Front Cardiovasc Med. 2025 Aug 8;12:1638515. doi: 10.3389/fcvm.2025.1638515. eCollection 2025.
2
Bronchial anastomotic complications as a microvascular disruption in a mouse model of airway transplantation.支气管吻合口并发症作为气道移植小鼠模型中的微血管破坏。
Front Immunol. 2025 May 14;16:1567657. doi: 10.3389/fimmu.2025.1567657. eCollection 2025.
3
New Insights into Mitochondria in Health and Diseases.

本文引用的文献

1
AMPK and Pulmonary Hypertension: Crossroads Between Vasoconstriction and Vascular Remodeling.AMPK与肺动脉高压:血管收缩与血管重塑之间的交叉点
Front Cell Dev Biol. 2021 Jun 8;9:691585. doi: 10.3389/fcell.2021.691585. eCollection 2021.
2
C1q/TNF-related protein-9 ameliorates hypoxia-induced pulmonary hypertension by regulating secretion of endothelin-1 and nitric oxide mediated by AMPK in rats.C1q/TNF 相关蛋白-9 通过调节 AMPK 介导的内皮素-1 和一氧化氮的分泌来改善大鼠低氧性肺动脉高压。
Sci Rep. 2021 May 31;11(1):11372. doi: 10.1038/s41598-021-90779-2.
3
Targeting AMPK by Statins: A Potential Therapeutic Approach.
线粒体在健康与疾病中的新认识。
Int J Mol Sci. 2024 Sep 16;25(18):9975. doi: 10.3390/ijms25189975.
4
The role and mechanism of AMPK in pulmonary hypertension.AMPK 在肺动脉高压中的作用及其机制。
Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241271990. doi: 10.1177/17534666241271990.
5
Urolithin A Protects against Hypoxia-Induced Pulmonary Hypertension by Inhibiting Pulmonary Arterial Smooth Muscle Cell Pyroptosis via AMPK/NF-κB/NLRP3 Signaling.尿石素 A 通过 AMPK/NF-κB/NLRP3 信号通路抑制肺动脉平滑肌细胞焦亡来防治低氧性肺动脉高压。
Int J Mol Sci. 2024 Jul 28;25(15):8246. doi: 10.3390/ijms25158246.
6
Will AMPK be a potential therapeutic target for hepatocellular carcinoma?AMPK会成为肝细胞癌的潜在治疗靶点吗?
Am J Cancer Res. 2024 Jul 15;14(7):3241-3258. doi: 10.62347/YAVK1315. eCollection 2024.
7
Natural activators of AMPK signaling: potential role in the management of type-2 diabetes.AMPK信号通路的天然激活剂:在2型糖尿病管理中的潜在作用。
J Diabetes Metab Disord. 2022 Nov 8;22(1):47-59. doi: 10.1007/s40200-022-01155-4. eCollection 2023 Jun.
8
Protective effects of the Terminalia bellirica tannin-induced Nrf2/HO-1 signaling pathway in rats with high-altitude pulmonary hypertension.没食子酸棓单宁诱导 Nrf2/HO-1 信号通路对高原性肺动脉高压大鼠的保护作用。
BMC Complement Med Ther. 2023 May 6;23(1):150. doi: 10.1186/s12906-023-03981-2.
9
Effects of the peripheral CB receptor antagonist JD5037 in mono- and polytherapy with the AMPK activator metformin in a monocrotaline-induced rat model of pulmonary hypertension.外周CB受体拮抗剂JD5037与AMPK激活剂二甲双胍单药及联合治疗在野百合碱诱导的大鼠肺动脉高压模型中的作用
Front Pharmacol. 2022 Sep 2;13:965613. doi: 10.3389/fphar.2022.965613. eCollection 2022.
他汀类药物靶向 AMPK:一种潜在的治疗方法。
Drugs. 2021 Jun;81(8):923-933. doi: 10.1007/s40265-021-01510-4. Epub 2021 May 3.
4
Resveratrol: Mechanistic and therapeutic perspectives in pulmonary arterial hypertension.白藜芦醇在肺动脉高压中的作用机制及治疗前景。
Pharmacol Res. 2021 Jan;163:105287. doi: 10.1016/j.phrs.2020.105287. Epub 2020 Nov 4.
5
Long-term chronic intermittent hypoxia: a particular form of chronic high-altitude pulmonary hypertension.长期慢性间歇性缺氧:慢性高原性肺动脉高压的一种特殊形式。
Pulm Circ. 2020 Oct 13;10(1 Suppl):5-12. doi: 10.1177/2045894020934625. eCollection 2020 Jul-Sep.
6
Oxidative Stress, Kinase Activity and Inflammatory Implications in Right Ventricular Hypertrophy and Heart Failure under Hypobaric Hypoxia.低氧低压环境下右心室肥厚和心力衰竭中的氧化应激、激酶活性和炎症影响。
Int J Mol Sci. 2020 Sep 3;21(17):6421. doi: 10.3390/ijms21176421.
7
Pharmacologic therapy for pulmonary artery hypertension.肺动脉高压的药物治疗。
Curr Opin Cardiol. 2020 Nov;35(6):643-656. doi: 10.1097/HCO.0000000000000796.
8
Endothelial function and shear stress in hypobaric hypoxia: time course and impact of plasma volume expansion in men.低气压缺氧时的内皮功能和切变应力:男性血浆容量扩张的时程和影响。
Am J Physiol Heart Circ Physiol. 2020 Nov 1;319(5):H980-H994. doi: 10.1152/ajpheart.00597.2020. Epub 2020 Sep 4.
9
Protein biomarkers and risk scores in pulmonary arterial hypertension associated with ventricular septal defect: integration of multi-omics and validation.蛋白生物标志物和风险评分在与室间隔缺损相关的肺动脉高压中的作用:多组学整合与验证。
Am J Physiol Lung Cell Mol Physiol. 2020 Nov 1;319(5):L810-L822. doi: 10.1152/ajplung.00167.2020. Epub 2020 Sep 2.
10
MDM2-Mediated Ubiquitination of Angiotensin-Converting Enzyme 2 Contributes to the Development of Pulmonary Arterial Hypertension.MDM2 介导的血管紧张素转换酶 2 泛素化参与肺动脉高压的发生。
Circulation. 2020 Sep 22;142(12):1190-1204. doi: 10.1161/CIRCULATIONAHA.120.048191. Epub 2020 Jul 28.